Upgrading X-ray crystallography equipment at the University of Arkansas in Fayetteville has had an unexpected benefit: enabling analyses that could help art museums authenticate, restore, and learn more about their pieces.

Scientists use X-ray crystallography to determine the detailed 3D structures of molecules. In biomedical contexts, researchers often apply X-ray crystallography to map the structures of proteins and other biomolecules like DNA and RNA. A molecule’s structure can shed light on its function and help answer scientific questions. For example, knowing the structures of proteins involved in antibiotic resistance can help researchers determine how those molecules work and how to combat bacteria that produce them.

In 2021, we shared the perspectives of third-year undergraduates who had recently joined the first cohort of the Maximizing Access to Research Careers (MARC) program at Vanderbilt University in Nashville, Tennessee. Vanderbilt’s MARC program provides mentorship and professional development opportunities to third- and fourth-year undergraduates who plan to pursue advanced degrees and are from groups that are underrepresented in the biomedical sciences. In spring 2022, as the cohort prepared for graduation, we followed up on their progress and postgraduation plans.

“I feel really pleased with how well our students have done despite entering the program in the midst of the COVID-19 pandemic,” says Katherine Friedman, Ph.D., an associate professor of biological sciences at Vanderbilt and a co-director of its MARC program. Four of the six first-cohort students are entering doctoral programs in fall 2022, and the other two have made preparations to pursue higher degrees at a later date.

“In my lab, we’ve been gene hunters—starting with visible phenotypes, or characteristics, and searching for the responsible genes,” says Miriam Meisler, Ph.D., the Myron Levine Distinguished University Professor at the University of Michigan Medical School in Ann Arbor. During her career, Dr. Meisler has identified the functions of multiple genes and has shown how genetic variants, or mutations, can impact human health.

Becoming a Scientist

Dr. Meisler had a strong interest in science as a child, which she credits to “growing up at the time of Sputnik” and receiving encouragement from her father and excellent science teachers in high school and college. However, when she started her undergraduate studies at Antioch College in Yellow Spring, Ohio, she decided to explore the humanities and social sciences. After 2 years of sociology and anthropology classes, she returned to biomedical science and, at a student swap, symbolically traded her dictionary for a slide rule—a mechanical device used to do calculations that was eventually replaced by the electric calculator.

“As a researcher, you get to learn something new every day, and that knowledge feeds more questions. It’s this eternal learning process, and I find that really enticing about being in science,” says Eszter Boros, Ph.D., an assistant professor of chemistry at Stony Brook University in Stony Brook, New York. Our interview with Dr. Boros highlights her journey of becoming a scientist and her research on biomedical applications of metals.

Q: What drew you to science?

A: I was born and raised in Switzerland, and I went to a linguistics-focused high school there, but I gravitated to chemistry because I loved that we could understand the world at a molecular level and see the macroscopic consequences of microscopic processes.

When you encounter the word expression, you may think of a smile, a grimace, or another look on someone’s face. But when biologists talk about expression, they typically mean the process of gene expression—when the information in a gene directs protein synthesis. Proteins are essential for virtually every process in the human body.

Over the past 2 years, you’ve probably heard a lot about the spread of SARS-CoV-2—the virus that causes COVID-19—and the emergence of variants. The discovery and tracking of these variants is possible thanks to genomic surveillance, a technique that involves sequencing and analyzing the genomes of SARS-CoV-2 virus particles from many COVID-19 patients. Genomic surveillance has not only shed light on how SARS-CoV-2 has evolved and spread, but it has also helped public health officials decide when to introduce measures to help protect people.

In December 2021, the NIGMS-supported SARS-CoV-2 genomic surveillance program at the University of New Mexico Health Science Center (UNM HSC) in Albuquerque detected the first known case of the Omicron variant in the state, which enabled a rapid public health response. The program’s co-leaders, assistant professors Darrell Dinwiddie, Ph.D., and Daryl Domman, Ph.D., were watching on high alert for it to enter New Mexico, and when it did, they were poised to quickly identify it:

“I study the dance between a bacterium and its host. If we can decode the secrets of that dance—how the pathogen causes disease, and how the host fights back—we might be able to take advantage of vulnerabilities to improve our ability to combat infections,” says Víctor J. Torres, Ph.D., the C. V. Starr Professor of Microbiology at the New York University (NYU) Grossman School of Medicine in New York City.

Discovering and Pursuing a Passion for Science

Growing up, Dr. Torres never would have imagined his highly successful scientific career, especially since he didn’t have a strong interest in science. He entered the University of Puerto Rico, Mayagüez, in 1995, planning to participate in the Reserve Officers’ Training Corps and join the Air Force after graduation. He struggled during his first year of college and had to repeat several courses. In one of those courses, he met a fellow student who was planning to pursue a career in science—his now wife, Carmen A. Perez, M.D., Ph.D., who’s a radiation oncologist at NYU Langone. She shared with Dr. Torres some of the opportunities in science available to him, including the NIGMS-funded Maximizing Access to Research Careers (MARC) program at their university.

RNA, though less well known than its cousin DNA, is equally integral to our bodies. RNA molecules are long, usually single-stranded chains of nucleotides. (DNA molecules are also made up of nucleotides but are typically double-stranded.) There are three major types of RNA, which are all involved in protein synthesis:

• Messenger RNA (mRNA) is complementary to one of the DNA strands of a gene and carries genetic information for protein synthesis to the ribosome—the molecular complex in which proteins are made.
• Transfer RNA (tRNA) works with mRNA to make sure the right amino acids are inserted into the forming protein.
• Ribosomal RNA (rRNA), together with proteins, makes up ribosomes and functions to recognize the mRNA and tRNA that are presented to the ribosomal complex.

“I find it fulfilling to be a scientist because I know that even if at some points it seems like I’m working on an incremental experiment, eventually it’s going to help solve a bigger problem,” says Caroline Jones, Ph.D., an assistant professor of bioengineering at the University of Texas at Dallas. Check out the highlights of our interview with Dr. Jones to learn about her career path, her passion for sharing science with the public, and her research on sepsis—an overwhelming or impaired whole-body immune response to an insult, such as an infection or injury that’s responsible for the deaths of nearly 270,000 Americans every year.

Q: How did you first become interested in science?

A: My mother was a high school math teacher, so I had that role model growing up. I also had a math and engineering teacher in high school who encouraged me and sparked my interest in the quantitative side of science. I decided to study biomedical engineering in college because I wanted to apply quantitative tools in a way that helped people.

“My parents told me that I already wanted to be a scientist when I was 7 or 8 years old. I don’t remember ever considering anything else,” says Ry Young, Ph.D., a professor of biochemistry, biophysics, and biology at Texas A&M University, College Station.

Dr. Young has been a researcher for more than 45 years and is a leading expert on bacteriophages—viruses that infect bacteria. He and other scientists have shown that phages, as bacteriophages are often called, could help us fight bacteria that have developed resistance to antibiotics. Antibiotic-resistant infections cause more than 35,000 deaths per year in the U.S., and new, effective treatments for them are urgently needed.